Implantica (Sweden) Insiders
| IMP-A-SDB | SEK 35.05 1.40 3.84% |
Implantica employs about 29 people. The company is managed by 9 executives with a total tenure of roughly 68 years, averaging almost 7.0 years of service per executive, having 3.22 employees per reported executive. Breaking down Implantica's management performance can provide insight into the firm performance.
| Stephan Siegenthaler Insider Chief Member |
| Nicole Pehrsson Insider Chief Officer |
Implantica |
Implantica Management Team Effectiveness
The company has return on total asset (ROA) of (0.0674) % which means that it has lost $0.0674 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.147) %, meaning that it generated substantial loss on money invested by shareholders. Implantica's management efficiency ratios could be used to measure how well Implantica manages its routine affairs as well as how well it operates its assets and liabilities.Implantica Workforce Comparison
Implantica AG is currently regarded as number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is currently estimated at about 21,301. Implantica adds roughly 29.0 in number of employees claiming only tiny portion of all equities under Medical Devices industry.
Implantica AG Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Implantica AG Price Series Summation is a cross summation of Implantica price series and its benchmark/peer.
Implantica Notable Stakeholders
An Implantica stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Implantica often face trade-offs trying to please all of them. Implantica's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Implantica's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Stephan Siegenthaler | Chief Member | Profile | |
| Nicole Pehrsson | Chief Officer | Profile | |
| Andreas hrnberg | Chief Officer | Profile | |
| Paul Mead | Chief Officer | Profile | |
| Stefan Vogt | Chief Officer | Profile | |
| Steffen Schanz | VP Management | Profile | |
| Amit Kukreja | Chief Officer | Profile | |
| Jrg MangerKoenig | Company Board | Profile | |
| Peter Forsell | Founder CEO | Profile |
About Implantica Management Performance
The success or failure of an entity such as Implantica AG often depends on how effective the management is. Implantica management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Implantica management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Implantica management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. The company was founded in 2015 and is based in Vaduz, Liechtenstein. Implantica is traded on Stockholm Stock Exchange in Sweden.
Please note, the imprecision that can be found in Implantica's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Implantica AG. Check Implantica's Beneish M Score to see the likelihood of Implantica's management manipulating its earnings.
Implantica Workforce Analysis
Traditionally, organizations such as Implantica use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Implantica within its industry.Implantica Manpower Efficiency
Return on Implantica Manpower
| Revenue Per Employee | 24.4K | |
| Revenue Per Executive | 78.6K | |
| Net Loss Per Employee | 529.7K | |
| Net Loss Per Executive | 1.7M |
Additional Tools for Implantica Stock Analysis
When running Implantica's price analysis, check to measure Implantica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Implantica is operating at the current time. Most of Implantica's value examination focuses on studying past and present price action to predict the probability of Implantica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Implantica's price. Additionally, you may evaluate how the addition of Implantica to your portfolios can decrease your overall portfolio volatility.